Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Surface plasmon resonance Stories

2012-08-29 07:01:39

Proteins adorning the surfaces of human cells perform an array of essential functions, including cell signaling, communication and the transport of vital substances into and out of cells. They are critical targets for drug delivery and many proteins are now being identified as disease biomarkers–early warning beacons announcing the pre-symptomatic presence of cancers and other diseases. While study of the binding properties of membrane proteins is essential, detailed analysis of...

2012-08-29 06:59:40

By modifying the rate at which chemical reactions take place, nanoparticle catalysts fulfill myriad roles in industry, the biomedical arena and everyday life. They may be used for the production of polymers and biofuels, for improving pollution and emission control devices, to enhance reactions essential for fuel cell technology and for the synthesis of new drugs. Finding new and more effective nanoparticle catalysts to perform these useful functions is therefore vital. Now Nongjian (NJ)...

2012-08-22 02:23:51

BOULDER, Colo., Aug. 22, 2012 /PRNewswire/ -- BiOptix today officially announced its fall 2012 Tradeshow and Symposia schedule. These events will highlight the BiOptix Enhanced Surface Plasmon Resonance (ESPR) technology and the forthcoming BiOptix 404pi, a novel and game-changing label-free SPR instrument for kinetic detection. BiOptix Events for fall 2012 include: 34th Semiannual Biotechnology Symposia, University of California, San Diego: August 23(rd) HUPO - 11th Annual World...

2012-06-27 10:25:31

BOULDER, Colo., June 27, 2012 /PRNewswire/ -- BiOptix announces the appointment of Michael W. Routh, Ph. D. to the Board of Directors of the firm, adding to a preeminent group of leaders driving BiOptix and its proprietary Enhanced Surface Plasmon Resonance platform toward continued success in the life science marketplace. BiOptix, a leader in the Surface Plasmon Resonance space today announced the appointment of Michael W. Routh, Ph.D. to the Board of Directors. "The appointment of Dr....

2012-06-15 10:23:12

BOULDER, Colo., June 15, 2012 /PRNewswire/ -- BiOptix, a Colorado-based firm, announces completion of a successful week of research shows in Colorado's Biotech Corridor. BiOptix today announced support of events this week at National Jewish Health, the University of Colorado Denver-Anschutz Medical Campus and at the University of Colorado, Boulder. These events brought Colorado-based researchers together with representatives of dozens of global life science research suppliers, and are a...

2012-04-30 02:22:17

BOULDER, Colo., April 30, 2012 /PRNewswire/ -- BiOptix today announced participation in the 8th Annual PEGS: Protein Engineering Summit, to be held in Boston April 30 - May 4, 2012. Supporting PEGS allows BiOptix to showcase a growing family of Enhanced Surface Plasmon Resonance Instrumentation, highlighting the BiOptix 104sa and the forthcoming BiOptix 404pi. "Participation in PEGS is a valuable opportunity for us to connect to our core customer," noted Ken Wilczek, Vice President of...

2012-04-26 10:21:18

BOULDER, Colo., April 26, 2012 /PRNewswire/ -- BiOptix today formally unveiled a new corporate brand identity and tag line: "Kinetics with Confidence," which is designed to promote the company's mission to transform how scientists perform label free kinetic analysis on proteins, nucleic acids and small molecules. "BiOptix is rapidly expanding, and we needed a brand and corporate identity that reflects the aspirations of the company as well as communicates our value proposition to...

2012-03-24 04:57:29

Berkeley Lab researchers embed artificial membranes with billions of nanoantennas for enhanced optical studies At the heart of the immune system that protects our bodies from disease and foreign invaders is a vast and complex communications network involving millions of cells, sending and receiving chemical signals that can mean life or death. At the heart of this vast cellular signaling network are interactions between billions of proteins and other biomolecules. These interactions, in...

2012-03-21 15:40:17

Positive identification of plasmons in nano particles could open new engineering possibilities at the nanoscale The physical phenomenon of plasmon resonances in small metal particles has been used for centuries. They are visible in the vibrant hues of the great stained-glass windows of the world. More recently, plasmon resonances have been used by engineers to develop new, light-activated cancer treatments and to enhance light absorption in photovoltaics and photocatalysis. "The...

2011-10-11 07:00:00

BEIJING, Oct. 11, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has received two patents from the United Kingdom Intellectual Property Office (the "UKIPO") and Notice of Allowance for four patent applications from the United States Patent and Trademark Office (the "USPTO"). All patents relate to the Company's SPR technology. Patent granted by...